Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T15:42:09.031Z.
Calculation as of: 2026-10-06T15:42:09.031Z.
Quote observation: 2026-10-06T15:38:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9eab42942c27d7457dfc33c45bb783e1a271ca5ab59202131f9efdd6250b8ad0
PE RATIO
N/A
Market Cap
$9.15M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.26M
PE Ratio
N/A
TTM Avg
38.25
3Y Avg
38.25
5Y Avg
38.25
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $8.53M | N/A | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.37M | N/A | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.17M | N/A | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.00M | N/A | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.96M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.94M | N/A | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $7.93M | N/A | 0.17 | 0.28 | 0.28 |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.15M | N/A | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.26M | N/A | 38.25 | 38.25 | 38.25 |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.29M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$0.57
Forward EPS (Est.)
$-10.23
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
